Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Scancell Holdings PLC (PK) SCNLF

Healthcare Biotechnology
Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma; and SC134, an antibody for the treatment of small cell lung cancer. It also develops Modi-1, an active peptide immunotherapy that is in phase... see more

Current News (PINL:SCNLF)

No current news is available.
View More News ››

Opinion & Analysis (PINL:SCNLF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (PINL:SCNLF)

Scancell to give AACR presentation on SCIB1 vaccine

Scancell is to present interim data on their SCIB1 vaccine at this month's Annual Meeting of the American Association for Cancer...
MarsBarsAtDawn - April 7, 2014

Scancell's remarkable history of success

Scancell, founded in 1997, hit the ground running with an early, protein version, of their ImmunoBody vaccine which successfully treated...
MarsBarsAtDawn - March 26, 2014

RE:RE:Scancell - breakthrough in cancer treatment

The CEO has said that the first deal he expects to make is for a product from Scancell's Moditope platform. He also said on...
fightfear - March 26, 2014

New article from Stock Oracle

Scancell Could Explode Any Time! Stock Oracle
MarsBarsAtDawn - March 23, 2014

RE:Scancell - breakthrough in cancer treatment

Yervoy $1b revenue in 2 years Bristol Myers has done 18 trials, nearly all of them involve the drug ipilimumab (a bit like Scancell’s...
fightfear - March 20, 2014

Scancell - breakthrough in cancer treatment

I've been long on Scnacell for quite some time, and I've shifted all my funds there, despite promising myself never to be "...
fightfear - March 19, 2014
View more Bullboard ››

Nightfood Holdings, Inc.

Nightfood Holdings, Inc.

Nightfood Holdings, Inc., through its subsidiaries, operates as a hospitality technology company. It operates through ...
View More »

Podcasts